The "Art" of Medicine and The "Smokescreen" of the Randomized Trial Off-Label Use of Vascular Devices

被引:5
|
作者
Ansel, Gary M. [1 ]
Jaff, Michael R. [2 ]
机构
[1] Univ Toledo, Sch Med, Ctr Crit Limb Care, Riverside Methodist Hosp, Columbus, OH 43214 USA
[2] Massachusetts Gen Hosp, Dept Med, Vasc Ctr, Div Cardiol Vasc Med, Boston, MA 02114 USA
关键词
peripheral vascular disease; stent; angioplasty; regulatory; off-label;
D O I
10.1002/ccd.21776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Once a device is approved for sale in the United States by the Food and Drug Administration (FDA), it can legally be used by doctors to treat any condition a physician determines is medically appropriate. Based on postmarket published data and physician procedural experience, this may even become the standard of care when an alternative device either does not exist or is inferior in performance, even before FDA approval. This right of physicians to practice medicine without FDA approval is Federal law. The off-label use of medical devices for the treatment of peripheral vascular disease has recently become the latest target by groups with interests that have little to do with patient care. This interference has begun to negatively impact the latitude necessary for physicians to best treat their patients. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:998 / 1002
页数:5
相关论文
共 50 条
  • [1] Off-label use of antipsychotics: Rethinking "off-label"
    Groleger, Urban
    PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
  • [2] Off-label use of medicine in pediatrics: focus on gastrointestinal diseases
    Karesh, Alyson
    Tomaino, Juli
    Mulberg, Andrew E.
    CURRENT OPINION IN PEDIATRICS, 2013, 25 (05) : 612 - 617
  • [3] "Off-Label" Use of DNS
    Wala, Fatema Bannat
    Cotton, Chase
    DIGITAL THREATS: RESEARCH AND PRACTICE, 2022, 3 (03):
  • [4] Off-Label Use of the WEB Device
    Zanaty, Mario
    Roa, Jorge A.
    Tjoumakaris, Stavropoula, I
    Jabbour, Pascal
    Mouchtouris, Nikolaos
    Sweid, Ahmad
    Ortega-Gutierrez, Santiago
    Ishii, Daizo
    Limaye, Kaustubh
    Asi, Khaled
    Samaniego, Edgar A.
    Hasan, David M.
    WORLD NEUROSURGERY, 2020, 134 : E1047 - E1052
  • [5] Off-label use of contrast agents
    P. Reimer
    R. Vosshenrich
    European Radiology, 2008, 18 : 1096 - 1101
  • [6] Use of pharmaceuticals 'Off-Label' in the neonate
    Tobin, Joseph R.
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2010, 24 (03) : 451 - 460
  • [7] Off-label use of contrast agents
    Reimer, P.
    Vosshenrich, R.
    EUROPEAN RADIOLOGY, 2008, 18 (06) : 1096 - 1101
  • [8] Off-Label Promotion of Prescription Medicine: Is It Ever Justifiable?
    Ghinea, Narcyz
    Lipworth, Wendy
    Kerridge, Ian
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (03) : 359 - 363
  • [9] Pediatric Interventional Cardiology in the United States is Dependent on the Off-label Use of Medical Devices
    Sutherell, Jamie S.
    Hirsch, Russel
    Beekman, Robert H., III
    CONGENITAL HEART DISEASE, 2010, 5 (01) : 2 - 7
  • [10] Hypoglycemia associated with off-label sitagliptin use
    Whitley, Heather P.
    Kelley, Kristi
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2008, 1 : 3 - 5